Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).
Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.
Bisacodyl is indicated to relieve occasional constipation and irregularity.
Local Institution - 0001, Madison, Wisconsin, United States
Methodist Moody Brain and Spine Institute, Methodist Dallas Medical Center, Dallas, Texas, United States
University of California San Diego, La Jolla, California, United States
TARGID, Leuven, Belgium
Queen Mary University of London, London, United Kingdom
University College London, London, United Kingdom
University of Nottingham, Nottingham, Notts, United Kingdom
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Franklin Gastroenterology, PLLC, Franklin, Tennessee, United States
Indiana University Hospital, Indianapolis, Indiana, United States
Pinnacle Research Group, LLC, Anniston, Alabama, United States
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (there may be other sites in this country), Sao Paulo, Brazil
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.